Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C

PharmNet Research Team

Research output: Contribution to journalArticle

Abstract

Background: Evidence-based harm reduction intervention components which might benefit pharmacy patients have not been integrated and studied. Objective: To investigate the feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C called PharmNet. Methods: Indiana managing pharmacists were surveyed in 2018 to assess the feasibility and acceptability of an intervention for opioid misuse screening, brief intervention, syringe and naloxone dispensing, and referrals provision. The Consolidated Framework for Implementation Research informed the survey development and analysis. Results: The sample included 303 (30.8%) pharmacists; 215 (70.9%) provided detailed written comments. Intervention Characteristics: 83.3% believed PharmNet would benefit patients, and that staff could deliver the intervention with adequate training (70.0%). Inner Setting: While 77.2% believed their pharmacy culture supported practice change, 57.5% of chain pharmacists believed their pharmacies would not have time for PharmNet. Outer Setting: 73.3% believed additional addiction and overdose screening is needed in their community, and pharmacies should offer new services to help reduce opioid overdose and addiction among their patients (79.5%). A vast majority (97.7%) were asked by patients in the past 2 years about syringe related issues; 67.7% were asked about syringes for non-prescription injection drug use. Individuals Involved: While 62.4% believed PharmNet was within pharmacy scope of practice and 90.1% were comfortable consulting about syringe use, pharmacists reported that they had limited control over the implementation environment. Process: 38.0% of pharmacists indicated interest in advising the development of PharmNet. Conclusions: An implementation trial of a modified version of PharmNet is likely feasible; yet will be challenged by structural pressures particularly in chain pharmacies. Successful implementation will involve the development of resources and policy components to manage outer and inner setting characteristics and align the intervention to the implementation environment.

Original languageEnglish (US)
JournalResearch in Social and Administrative Pharmacy
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Harm Reduction
Syringes
Hepatitis C
Pharmacists
Opioid Analgesics
HIV
Pharmacies
Screening
Nonprescription Drugs
Naloxone
Policy Making
Referral and Consultation
Pressure
Injections
Pharmaceutical Preparations
Research

Keywords

  • Consolidated framework for implementation research
  • Harm reduction
  • Hepatitis C
  • HIV
  • Naloxone access
  • Opioid overdose reduction
  • Pharmacy practice
  • Syringe access

ASJC Scopus subject areas

  • Pharmacy
  • Pharmaceutical Science

Cite this

@article{2857f0561c47410087ffa2e39aa5f6f7,
title = "Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C",
abstract = "Background: Evidence-based harm reduction intervention components which might benefit pharmacy patients have not been integrated and studied. Objective: To investigate the feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C called PharmNet. Methods: Indiana managing pharmacists were surveyed in 2018 to assess the feasibility and acceptability of an intervention for opioid misuse screening, brief intervention, syringe and naloxone dispensing, and referrals provision. The Consolidated Framework for Implementation Research informed the survey development and analysis. Results: The sample included 303 (30.8{\%}) pharmacists; 215 (70.9{\%}) provided detailed written comments. Intervention Characteristics: 83.3{\%} believed PharmNet would benefit patients, and that staff could deliver the intervention with adequate training (70.0{\%}). Inner Setting: While 77.2{\%} believed their pharmacy culture supported practice change, 57.5{\%} of chain pharmacists believed their pharmacies would not have time for PharmNet. Outer Setting: 73.3{\%} believed additional addiction and overdose screening is needed in their community, and pharmacies should offer new services to help reduce opioid overdose and addiction among their patients (79.5{\%}). A vast majority (97.7{\%}) were asked by patients in the past 2 years about syringe related issues; 67.7{\%} were asked about syringes for non-prescription injection drug use. Individuals Involved: While 62.4{\%} believed PharmNet was within pharmacy scope of practice and 90.1{\%} were comfortable consulting about syringe use, pharmacists reported that they had limited control over the implementation environment. Process: 38.0{\%} of pharmacists indicated interest in advising the development of PharmNet. Conclusions: An implementation trial of a modified version of PharmNet is likely feasible; yet will be challenged by structural pressures particularly in chain pharmacies. Successful implementation will involve the development of resources and policy components to manage outer and inner setting characteristics and align the intervention to the implementation environment.",
keywords = "Consolidated framework for implementation research, Harm reduction, Hepatitis C, HIV, Naloxone access, Opioid overdose reduction, Pharmacy practice, Syringe access",
author = "{PharmNet Research Team} and Meyerson, {B. E.} and Agley, {J. D.} and W. Jayawardene and Eldridge, {L. A.} and P. Arora and C. Smith and N. Vadiei and A. Kennedy and T. Moehling",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.sapharm.2019.08.026",
language = "English (US)",
journal = "Research in Social and Administrative Pharmacy",
issn = "1551-7411",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C

AU - PharmNet Research Team

AU - Meyerson, B. E.

AU - Agley, J. D.

AU - Jayawardene, W.

AU - Eldridge, L. A.

AU - Arora, P.

AU - Smith, C.

AU - Vadiei, N.

AU - Kennedy, A.

AU - Moehling, T.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Evidence-based harm reduction intervention components which might benefit pharmacy patients have not been integrated and studied. Objective: To investigate the feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C called PharmNet. Methods: Indiana managing pharmacists were surveyed in 2018 to assess the feasibility and acceptability of an intervention for opioid misuse screening, brief intervention, syringe and naloxone dispensing, and referrals provision. The Consolidated Framework for Implementation Research informed the survey development and analysis. Results: The sample included 303 (30.8%) pharmacists; 215 (70.9%) provided detailed written comments. Intervention Characteristics: 83.3% believed PharmNet would benefit patients, and that staff could deliver the intervention with adequate training (70.0%). Inner Setting: While 77.2% believed their pharmacy culture supported practice change, 57.5% of chain pharmacists believed their pharmacies would not have time for PharmNet. Outer Setting: 73.3% believed additional addiction and overdose screening is needed in their community, and pharmacies should offer new services to help reduce opioid overdose and addiction among their patients (79.5%). A vast majority (97.7%) were asked by patients in the past 2 years about syringe related issues; 67.7% were asked about syringes for non-prescription injection drug use. Individuals Involved: While 62.4% believed PharmNet was within pharmacy scope of practice and 90.1% were comfortable consulting about syringe use, pharmacists reported that they had limited control over the implementation environment. Process: 38.0% of pharmacists indicated interest in advising the development of PharmNet. Conclusions: An implementation trial of a modified version of PharmNet is likely feasible; yet will be challenged by structural pressures particularly in chain pharmacies. Successful implementation will involve the development of resources and policy components to manage outer and inner setting characteristics and align the intervention to the implementation environment.

AB - Background: Evidence-based harm reduction intervention components which might benefit pharmacy patients have not been integrated and studied. Objective: To investigate the feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C called PharmNet. Methods: Indiana managing pharmacists were surveyed in 2018 to assess the feasibility and acceptability of an intervention for opioid misuse screening, brief intervention, syringe and naloxone dispensing, and referrals provision. The Consolidated Framework for Implementation Research informed the survey development and analysis. Results: The sample included 303 (30.8%) pharmacists; 215 (70.9%) provided detailed written comments. Intervention Characteristics: 83.3% believed PharmNet would benefit patients, and that staff could deliver the intervention with adequate training (70.0%). Inner Setting: While 77.2% believed their pharmacy culture supported practice change, 57.5% of chain pharmacists believed their pharmacies would not have time for PharmNet. Outer Setting: 73.3% believed additional addiction and overdose screening is needed in their community, and pharmacies should offer new services to help reduce opioid overdose and addiction among their patients (79.5%). A vast majority (97.7%) were asked by patients in the past 2 years about syringe related issues; 67.7% were asked about syringes for non-prescription injection drug use. Individuals Involved: While 62.4% believed PharmNet was within pharmacy scope of practice and 90.1% were comfortable consulting about syringe use, pharmacists reported that they had limited control over the implementation environment. Process: 38.0% of pharmacists indicated interest in advising the development of PharmNet. Conclusions: An implementation trial of a modified version of PharmNet is likely feasible; yet will be challenged by structural pressures particularly in chain pharmacies. Successful implementation will involve the development of resources and policy components to manage outer and inner setting characteristics and align the intervention to the implementation environment.

KW - Consolidated framework for implementation research

KW - Harm reduction

KW - Hepatitis C

KW - HIV

KW - Naloxone access

KW - Opioid overdose reduction

KW - Pharmacy practice

KW - Syringe access

UR - http://www.scopus.com/inward/record.url?scp=85073196614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073196614&partnerID=8YFLogxK

U2 - 10.1016/j.sapharm.2019.08.026

DO - 10.1016/j.sapharm.2019.08.026

M3 - Article

AN - SCOPUS:85073196614

JO - Research in Social and Administrative Pharmacy

JF - Research in Social and Administrative Pharmacy

SN - 1551-7411

ER -